Monday, May 13, 2024
Home Biotech News Page 54

Biotech News

    Latest
    zestra, biotech stock review

    Innovus (INNV) Zestra® Female Sexual Arousal Oils Featured in NY Times.

    eCommerce Editor / Curator -
    Erin Drought, a 28-year-old information technology consultant in Edmonton, Alberta, who says her sex drive evaporated after she began taking medicine for...
    Biotech Stock Review

    Christopher E. Rivera Appointed to the Council of Washington Biotechnology & Biomedical Association

    Health $ Fitness Editor / Curator -
    WASHINGTON, DC and SEATTLE, WA – (June 27, 2011) – Today the Washington Biotechnology & Biomedical Association (WBBA) and the Biotechnology Industry...

    Circle Group / Z-Trim (CRGQ/ZTRM) $2.50. Report.

    Research Editor / Curator -
    Download Circle Group - Z-Trim Report

    Circle Group Holdings (CRGQ) $0.47 Report.

    Research Editor / Curator -
    Click to Download. Client, we were compensated with 100,000 shares and warrants to purchase...
    1...525354Page 54 of 54

    Latest article

    COVID-19 Immunity From mRNA Booster Does Not Last Very Long.

    Biotech News Editor / Curator -
    Study finds that the median length for the antibody half-life immune response was 63 days for the primary series, and increased to...

    We’re in Tampa for the Kentucky Derby.

    Biotech News Editor / Curator -
    GeoVax (GOVX), Sees a Little Volume. Normally, we get a little nervous when one of the companies we...

    Institutional Analyst Newsletter. Citius (CTXR), GeoVax (GOVX.

    Institutional Analyst Newsletter Editor / Curator -
    DERBY WEEKEND - WE'RE HEADED TO TAMPA!HAT'S ON, DRINK'S UPADDING CITIUS PHARMA (CTXR) $0.66, TO WATCHLISTUPDATING GEOVAX LABS (GOVX) $1.43OUR $26...
    The Internet Stock Review is one of Wall Streets oldest newsletters covering internet technology having launched in 1999. The Biotech Stock Review is rather old too, having launched in 2002. We make our money by purchasing stock with our services, so the better our client stocks do, the better we all do. And when we're wrong, we feel the pain too! See our research reports for important disclaimer details. Content is provided by Institutional Analyst Inc., the website is managed by Revelers.IO Media Group Inc. To see if your Company qualifies for coverage, call 310-594-8062
    Contact us: [email protected]
    © Managed by Revelers.IO Media Group Inc.